中(zhong)證網訊(xun) 海翔藥(yao)業(002099)3月12日午間公(gong)告(gao),3月12日,公(gong)司(si)參加(jia)了浙(zhe)(zhe)江(jiang)(jiang)新東港藥(yao)業股份有(you)限公(gong)司(si)45%股權(quan)(quan)轉讓電子競價會, 最終(zhong)公(gong)司(si)未能競拍取得上述(shu)股權(quan)(quan)。公(gong)司(si)向浙(zhe)(zhe)江(jiang)(jiang)產權(quan)(quan)交易(yi)所有(you)限公(gong)司(si)繳納的4億(yi)元保證金將(jiang)于2個工作日內退還。
此(ci)前,公(gong)(gong)(gong)司(si)公(gong)(gong)(gong)告,浙江(jiang)物產化(hua)工集團有(you)限公(gong)(gong)(gong)司(si)持(chi)有(you)浙江(jiang)新東港藥業(ye)股(gu)(gu)份有(you)限公(gong)(gong)(gong)司(si)45%股(gu)(gu)權,于(yu)2018年2月1日至2018年3月5日在浙江(jiang)產權交易所(suo)有(you)限公(gong)(gong)(gong)司(si)掛(gua)牌轉讓,掛(gua)牌轉讓起始價為105,000萬元(yuan)(yuan)。為提升公(gong)(gong)(gong)司(si)盈利能力、豐富醫藥板塊(kuai)產品種類,公(gong)(gong)(gong)司(si)擬以(yi)不超(chao)過(guo)20億元(yuan)(yuan)(含(han)20億元(yuan)(yuan))參與競(jing)拍新東港藥業(ye)45%股(gu)(gu)權。(陳(chen)健健)